[{"ImageID": 0, "Page": 2, "Type": "Figure", "Imagebbox": [0.06297709923664122, 0.2860509776536313, 0.47137404580152664, 0.5164979050279329], "Caption": "Fig. 2. Bland-Altman plot of agreement between the true volumes of Through close collaboration with expert radiologists, and based on the our data and the prolate ellipsoid volume estimates illustrates a large outlined issues, we have identified the following challenges: error for large organs. CCC is moderate: r=0.9125 (95% CI 0.81 - 0.93), mean=77.3 \u00b1 142.64). The plot shows that the estimation method does RQ1 Observation of progressive changes in the spleen over time and not perform well for large spleens of sick subjects, which are those that their comparison to standard measurements. What are the actual require monitoring of changes. changes happening to the organ when its volume decreases [30]", "DPI": 100, "CaptionBB": [28, 560, 742, 640], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 1, "Page": 2, "Type": "Figure", "Imagebbox": [0.03571428571428571, 0.05001745810055866, 0.46946564885496184, 0.1568627450980392], "Caption": "Assessment of Splenomegaly. O\u2019Reilly et al. [30] have studied Fig. 1. Measurements of (a) the spleen\u2019s width and thickness taken 2,505 cases of splenomegaly accompanying lymphoma, AIDS, splenic on (b) the slice with maximal axial width and (c) the slice selected by cysts, and splanchnic vein obstruction. They found that progressive an expert radiologist. In this case, the splenic volume is calculated as 368.6 and 281.2 mL for the automatic for prolate ellipsoid [47] and Rezai splenic enlargement demands diagnostic study because these patients [35] methods and 632.6 and 462.6 mL for the observer measurement, usually have a hematologic cancer.", "DPI": 100, "CaptionBB": [28, 167, 743, 239], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 2, "Page": 4, "Type": "Figure", "Imagebbox": [0.13740458015267176, 0.05001745810055866, 0.8301526717557252, 0.25770308123249297], "Caption": "Fig. 3. An overview of the steps required for temporal feature analysis by AnaFe. The data is sourced from follow-up CT scans (a) that have been segmented (b). In this work, we first derive robust image features from the field of radiomics (c): texture, shape, intensity, and measurements. These features, along with other study information (non-image features), are used by our web-based application AnaFe. After selection of the current subject (d), the application performs a search for subjects with similar progression. Search results filtering is performed by brushing a selection over the distribution charts (f) of average features and average change in progression (interchangeable views shown with a double yellow arrow.)", "DPI": 100, "CaptionBB": [28, 275, 743, 342], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 3, "Page": 5, "Type": "Figure", "Imagebbox": [0.5331632653061225, 0.056022408963585436, 0.9591836734693877, 0.2119514472455649], "Caption": "Fig. 5. An example scatterplot of Measurement Progression over Time (MPT). Red markers show measurements for a given subject (#11) at each follow-up visit. The dashed line connects the measurements showing the progression trend for this given subject. Grey markers show measurements within the population at each visit.", "DPI": 100, "CaptionBB": [405, 226, 756, 293], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 4, "Page": 5, "Type": "Figure", "Imagebbox": [0.5510204081632653, 0.2801120448179272, 0.9298469387755102, 0.4407096171802054], "Caption": "Fig. 6. An example of the OD view showing two spleens rigidly aligned. Small black arrows indicate the direction of change and are obtained from the result of non-rigid registration.", "DPI": 100, "CaptionBB": [405, 471, 757, 512], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 5, "Page": 5, "Type": "Figure", "Imagebbox": [0.05152671755725191, 0.051414106145251395, 0.5057251908396947, 0.24694483240223464], "Caption": "Fig. 5. An example scatterplot of Measurement Progression over Time (MPT). Red markers show measurements for a given subject (#11) at each follow-up visit. The dashed line connects the measurements showing the progression trend for this given subject. Grey markers show measurements within the population at each visit.", "DPI": 100, "CaptionBB": [405, 226, 756, 293], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 6, "Page": 6, "Type": "Figure", "Imagebbox": [0.4987244897959184, 0.051414106145251395, 0.9502551020408163, 0.42296918767507], "Caption": "Fig. 8. An example of feature histogram charts for an average cranio- caudal length of the spleen per subject, and average relative change over time. The exact value of the feature is available in the tooltip when hovering over a subject\u2019s rectangle. The color scheme of the chart is selected by the user and is applied to each feature histogram. The figure presents 4 available color schemes: unique by subject, by gender, by disease status, and by age.", "DPI": 100, "CaptionBB": [392, 466, 744, 559], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 7, "Page": 6, "Type": "Figure", "Imagebbox": [0.03443877551020408, 0.04722416201117319, 0.47900763358778625, 0.2987861811391223], "Caption": "Fig. 7. An example of linking via brushing support between \u201cvolume,\u201d \u201clength,\u201d and \u201cconvexity\u201d in the FDO view. By brushing in the \u201cvolume\u201d chart visualization, the user can compare how selected subjects are distributed in other charts. Subjects and timepoints outside the selected range are removed from the similarity comparison (row). If the feature is fully deselected via the checkbox, the respective column in the FPT heatmap is dimmed out.", "DPI": 100, "CaptionBB": [27, 327, 379, 420], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 8, "Page": 7, "Type": "Figure", "Imagebbox": [0.10841836734693877, 0.05042016806722689, 0.9056122448979592, 0.5667600373482726], "Caption": "Fig. 9. The result of similarity comparison for subject #19 (a): (b) based on all features; (c) measurement features only; (d) shape features only.", "DPI": 100, "CaptionBB": [41, 606, 741, 622], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 9, "Page": 8, "Type": "Figure", "Imagebbox": [0.07627118644067797, 0.04722416201117319, 0.8983050847457628, 0.33239962651727356], "Caption": "Fig. 10. An example of OD, SMO, and MPT views for 4 subjects. Case (b) was found to be the most similar to case (a) in the sick subject data. Both show the same decrease in organ volume. Cases (c) and (d) were found to be most similar among healthy subjects. While the spleen (c) decreased in volume, (d) remained almost unchanged.", "DPI": 100, "CaptionBB": [28, 357, 742, 398], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 10, "Page": 9, "Type": "Figure", "Imagebbox": [0.5178571428571429, 0.051353874883286646, 0.9681122448979592, 0.446311858076564], "Caption": "Fig. 11. An example of AnaFe use with prostate data. User interaction with the system is displayed in the average (top) and change FDO views (bottom). Hovering the mouse over the marker (subject #73) in the MPT view (a) links to all features for this subject in the FDO view. Selected subjects in the view (c) are highlighted across all FDO charts. Not selected subjects (b) are dimmed out in the FPT view.", "DPI": 100, "CaptionBB": [405, 483, 755, 563], "first_confirmed": false, "second_confirmed": false}]